List of bibliographic references
Number of relevant bibliographic references: 17.
| Ident. | Authors (with country if any) | Title |
|---|
| 000004 (2020) |
Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni] | COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. |
| 000035 (2020) |
Joanna Makowska [Pologne] ; Anna Lewandowska-Polak [Pologne] | Desensitization to biological agents used in rheumatology. |
| 000317 (2019) |
Bartlomiej Wawrzycki [Pologne] ; Dorota Krasowska [Pologne] ; Aldona Pietrzak [Pologne] ; Ewa Wielosz [Pologne] ; Maria Majdan [Pologne] ; Torello Lotti [Italie] | Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab. |
| 000575 (2018) |
Justyna Roszkiewicz [Pologne] ; Krzysztof Orczyk [Pologne] ; El Bieta Smolewska [Pologne] | Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis - single-centre experience. |
| 000628 (2019) |
Bartosz Urbaniak [Pologne] ; Szymon Plewa [Pologne] ; Agnieszka Klupczynska [Pologne] ; Dorota Sikorska [Pologne] ; Włodzimierz Samborski [Pologne] ; Zenon J. Kokot [Pologne] | Serum free amino acid levels in rheumatoid arthritis according to therapy and physical disability. |
| 000787 (2018) |
Violetta Opoka-Winiarska [Pologne] ; Zbigniew Uber [Pologne] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Irina Nikishina [Russie] ; Gra Yna D Bowska [Pologne] ; El Bieta Smolewska [Pologne] | Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial. |
| 000887 (2018) |
Joanna Gał Zowska [Pologne] | Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond. |
| 000E83 (????) |
Joel M. Kremer [États-Unis] ; Ricardo Blanco [Espagne] ; Anne-Marie Halland [Afrique du Sud] ; Marek Brzosko [Pologne] ; Ruben Burgos-Vargas [Mexique] ; Christopher M. Mela [Royaume-Uni] ; Lucy Rowell [Royaume-Uni] ; Roy M. Fleischmann [États-Unis] | Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial. |
| 001007 (2016) |
Maciej Tarnowski [Pologne] ; Agnieszka Paradowska-Gorycka [Pologne] ; Ewa D Browska-Zamojcin [Pologne] ; Michal Czerewaty [Pologne] ; Sylwia Słuczanowska-Gł Bowska [Pologne] ; Andrzej Pawlik [Pologne] | The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy. |
| 001128 (2016) |
Gerd R. Burmester [Allemagne] ; Andrea Rubbert-Roth [Allemagne] ; Alain Cantagrel [France] ; Stephen Hall [Australie] ; Piotr Leszczynski [Pologne] ; Daniel Feldman [Brésil] ; Madura J. Rangaraj [États-Unis] ; Georgia Roane [États-Unis] ; Charles Ludivico [États-Unis] ; Min Bao [États-Unis] ; Lucy Rowell [Royaume-Uni] ; Claire Davies [Royaume-Uni] ; Eduardo F. Mysler [Argentine] | Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA). |
| 001253 (2015) |
Anna Felis-Giemza [Pologne] ; Marzena Olesi Ska ; Katarzyna Wierkocka ; Ewa Wi Sik-Szewczyk ; Ewa Haładyj | Treatment of rheumatic diseases and hepatitis B virus coinfection. |
| 001254 (2015) |
Magdalena Chmieli Ska [Pologne] ; Marzena Olesi Ska [Pologne] ; Anna Felis-Giemza [Pologne] | Interleukin 6 blockage-induced neutropenia in a patient with rheumatoid arthritis and resolved hepatitis B. |
| 001255 (2015) |
Małgorzata Kwiatkowska [Pologne] ; Ewa Jednacz [Pologne] ; Lidia Rutkowska-Sak [Pologne] | Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome - effective treatment with tocilizumab. |
| 001256 (2015) |
Joanna Widrowska [Pologne] ; Agnieszka Zygmunt [Pologne] ; Małgorzata Biernacka-Zieli Ska [Pologne] ; Jerzy Sta Czyk [Pologne] ; El Bieta Smolewska [Pologne] | Influence of biologic therapy on growth in children with chronic inflammatory connective tissue diseases. |
| 001412 (2015) |
Hermine I. Brunner [États-Unis] ; Nicolino Ruperto [Italie] ; Zbigniew Zuber [Pologne] ; Caroline Keane [Royaume-Uni] ; Olivier Harari [Royaume-Uni] ; Andrew Kenwright [Royaume-Uni] ; Peng Lu [États-Unis] ; Ruben Cuttica [Argentine] ; Vladimir Keltsev [Russie] ; Ricardo M. Xavier [Brésil] ; Inmaculada Calvo [Espagne] ; Irina Nikishina [Russie] ; Nadina Rubio-Pérez [Mexique] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Gerd Horneff [Allemagne] ; Violetta Opoka-Winiarska [Pologne] ; Pierre Quartier [France] ; Clovis A. Silva [Brésil] ; Earl Silverman [Canada] ; Alberto Spindler [Argentine] ; Eileen Baildam [Royaume-Uni] ; M Luz Gámir [Espagne] ; Alan Martin [États-Unis] ; Christoph Rietschel [Allemagne] ; Daniel Siri [Argentine] ; Elzbieta Smolewska [Pologne] ; Daniel Lovell [États-Unis] ; Alberto Martini [Italie] ; Fabrizio De Benedetti [Italie] | Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. |
| 001A37 (2011) |
Jerzy Swierkot [Pologne] ; Marta Madej | [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors]. |
| 001A53 (2011) |
Ewa Orlewska [Pologne] ; Ioan Ancuta ; Branimir Anic ; Catalin Codrenau ; Nemanja Damjanov ; Predrag Djukic ; Ruxandra Ionescu ; Lubomir Marinchev ; Evgeny L. Nasonov ; Tonu Peets ; Sonja Praprotnik ; Rasho Rashkov ; Jana Skoupa ; Witold Tlustochowicz ; Malgorzata Tlustochowicz ; Matija Tomsic ; Tiina Veldi ; Jelena Vojinovic ; Piotr Wiland | Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/AffPays.i -k "Pologne"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/AffPays.i \
-Sk "Pologne" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= PubMed
|étape= Curation
|type= indexItem
|index= AffPays.i
|clé= Pologne
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
